penicillamine has been researched along with Sclerosis in 6 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Sclerosis: A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of pemphigus foliaceus arising during the administration of D-penicillamine was reported." | 7.73 | Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus. ( Amagai, M; Nagao, K; Tanikawa, A; Yamamoto, N, 2005) |
| "A case of pemphigus foliaceus arising during the administration of D-penicillamine was reported." | 3.73 | Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus. ( Amagai, M; Nagao, K; Tanikawa, A; Yamamoto, N, 2005) |
| " A patient and his young sister were shown to be suffering from spinal muscular atrophy with superimposed, excessive proliferative activity of fibroblasts, and in these cases a beneficial effect of penicillamine was demonstrated." | 3.65 | The syndrome of myosclerosis. ( Bradley, WG; Gardner-Medwin, D; Hudgson, P; Walton, JN, 1973) |
| "Primary sclerosing cholangitis and primary biliary cirrhosis are chronic cholestatic syndromes that may be difficult to differentiate clinically." | 2.66 | Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. ( Dickson, ER; LaRusso, NF; Ludwig, J; Wiesner, RH, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagao, K | 1 |
| Tanikawa, A | 1 |
| Yamamoto, N | 1 |
| Amagai, M | 1 |
| Lubach, D | 1 |
| Marghescu, S | 1 |
| From, E | 1 |
| Frederiksen, P | 1 |
| Melski, JW | 1 |
| Wiesner, RH | 1 |
| LaRusso, NF | 1 |
| Ludwig, J | 1 |
| Dickson, ER | 1 |
| Bradley, WG | 1 |
| Hudgson, P | 1 |
| Gardner-Medwin, D | 1 |
| Walton, JN | 1 |
1 trial available for penicillamine and Sclerosis
| Article | Year |
|---|---|
Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis.
Topics: Adult; Bile Ducts; Biopsy; Cholangiography; Cholangitis; Clinical Trials as Topic; Diagnosis, Differ | 1985 |
5 other studies available for penicillamine and Sclerosis
| Article | Year |
|---|---|
Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus.
Topics: Aged; Antirheumatic Agents; Autoantibodies; Cadherins; Desmoglein 1; Drug Eruptions; Enzyme-Linked I | 2005 |
[Yellow-nail syndrome from d-penicillamine].
Topics: Adult; Female; Humans; Lymphedema; Nail Diseases; Penicillamine; Pigmentation Disorders; Sclerosis; | 1979 |
Pemphigus vulgaris following D-penicillamine.
Topics: Biopsy; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Humans; Middle Aged; Pemp | 1976 |
Price of technology. A blind spot.
Topics: Deductibles and Coinsurance; Humans; Insurance, Health; Penicillamine; Photochemotherapy; Resource A | 1992 |
The syndrome of myosclerosis.
Topics: Adult; Child; Child, Preschool; Collagen; Diagnosis, Differential; Electromyography; Female; Humans; | 1973 |